Navigation Links
'Allergy cells' can aggravate cancer and psoriasis

The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances. However, researchers at Karolinska Institutet have now demonstrated how the mast cells can also contribute to diseases like psoriasis and cancer.

Mast cells are most known for their association with allergic reactions, as they act like microscopic "bombs" to trigger the release of a number of substances that give rise to the classic allergic symptoms, such as swelling, congestion and itching. The explosive reactions are activated when an allergen (such as pollen particles) binds to receptors on the surface of the mast cell, which then opens and secretes part of its contents.

In the past few years it has emerged that mast cells, which are a type of immune cell, are probably also involved in the development of a number of other diseases, like atopical eczema, psoriasis, and the Hodgkins lymphoma cancer type. These diseases are characterised by chronic inflammations and an increase in the number of mast cells. However, the mechanisms behind this are relatively unknown.

Associate professor Gunner Nilsson at Karolinska Institutet and his research group have now found a possible explanation for the link between mast cells and several non-allergic diseases. The study, which is presented online by The Journal of Clinical Investigation, shows that mast cells can be activated in a previously unknown way that might lead to chronic inflammation.

"These new findings contribute to our understanding of the part played by the mast cell in atopical eczema, psoriasis and Hodgkins Lymphoma," says Mr Nilsson. "We hope that our research will make it possible for scientists to develop new forms of therapy for the mast cell-related diseases."

The group discovered that the CD30 protein, which is found on the surface of the immune systems T-lymphocytes amongst other places, can stimulate mast cells to release prot eins that regulate the recruitment of inflammatory cells. Since it is already known that levels of CD30 are higher in people with psoriasis or atopical eczema and with Hodgkins lymphoma, the results can explain how the mast cells are activated and how they aggravate inflammation in these diseases.

Source:Karolinska Institutet

Related biology news :

1. Two chemicals boost immune cells ability to fight HIV without gene therapy
2. Once given no respect, cells tiny RNAS take drivers seat
3. How HIV disables the cells call for help
4. Stem cells electric abilities might help their safe clinical use
5. Scientists discover the molecular switch for nerve cells insulating jelly rolls
6. New insight into machinery of immune cells tentacles
7. Failure of scout cells may lead to cancer in transplant patients
8. A key antibody, IgG, links cells capture and disposal of germs
9. Viral DNA sequence a possible trigger for breast cancer
10. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
11. Its not all genetic: Common epigenetic problem doubles cancer risk in mice

Post Your Comments:

(Date:9/24/2015)... , September 24, 2015 ... 25 september 2015 Kerv ( ... digitala finanstjänster, lanserar idag världens första kontaktlösa ... samla in 77 000 GBP för massproduktion ... ) , Kerv-bärare ...
(Date:9/10/2015)... Sept. 10, 2015 Report Details ... quite delivered upon previous expectations of revenues, consumer adoption ... breakthrough year in which wearables begin to achieve that ... of the main reasons is the entrance of Apple ... the SmartWatches market, but the overall size of the ...
(Date:9/9/2015)... VANCOUVER, British Columbia , Sept. 9, 2015 ... achieved numerous organizational and solution-based milestones, furthering the ... the perils of online fraud. NuData ... key in enhancing the company,s growth cycle. The ... machine learning to determine good user behavior from ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... ... October 13, 2015 , ... SonaCare Medical, LLC, ... that it received de novo clearance from the U.S. Food and Drug Administration ... of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... Spirax Sarco, ... the release of the CSM-C 600 compact clean steam generator . This ... that meets the requirements of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 ...
(Date:10/12/2015)... ANNAPOLIS, Maryland , 12 de octubre de 2015 ... O. Matsui (D-CA) llegó a un récord en el ... tercera edición anual de la International Plasma Awareness Week ... octubre. La IPAW está patrocinada por la Plasma ... estando diseñada para: , Aumentar la ...
(Date:10/12/2015)... Belgium , Oct. 12, 2015 VolitionRx ... from a completed clinical study of its NuQ ® ... in the online issue of Clinical Epigenetics , the ... was conducted in collaboration with Lund ... Roland Andersson , MD, PhD, Professor of Surgery and Vice-Dean, ...
Breaking Biology Technology: